Cognitive Stimulation
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01271413 |
|
Recruitment Status :
Completed
First Posted : January 6, 2011
Results First Posted : March 7, 2014
Last Update Posted : April 16, 2014
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Substance Use Disorders | Behavioral: Computerized cognitively stimulating activities | Phase 2 |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 134 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Double (Participant, Outcomes Assessor) |
| Primary Purpose: | Treatment |
| Official Title: | Effects of Cognitive Training in Methadone Maintenance Patients |
| Study Start Date : | December 2010 |
| Actual Primary Completion Date : | July 2013 |
| Actual Study Completion Date : | July 2013 |
| Arm | Intervention/treatment |
|---|---|
| Experimental: Adaptive cognitively stimulating activities |
Behavioral: Computerized cognitively stimulating activities
The study will compare the effects of different methods of computerized mental stimulation. The intervention involves 25 sessions involving computerized cognitive tasks. |
| Active Comparator: Non-adaptive cognitively stimulating activities |
Behavioral: Computerized cognitively stimulating activities
The study will compare the effects of different methods of computerized mental stimulation. The intervention involves 25 sessions involving computerized cognitive tasks. |
- Working Memory [ Time Frame: baseline, 7 weeks ]Change in maximum number of digits correctly recalled in Digit Span Backwards task, from baseline to 7 weeks
- Episodic Memory [ Time Frame: baseline, 7 weeks ]
- Trail-making [ Time Frame: baseline, 7 weeks ]
- go/No-go [ Time Frame: baseline, 7 weeks ]
- Addiction Severity Index [ Time Frame: baseline, 7 weeks ]
- Delay Discounting [ Time Frame: baseline, 7 weeks ]
- Digit Symbol Substitution Test [ Time Frame: baseline, 7 weeks ]
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 55 Years (Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- age 18-55
- in methadone maintenance or healthy volunteers
- healthy
Exclusion Criteria:
- Axis I disorder (except substance abuse and dependence in methadone maintenance patients)
- severe cognitive impairment
- serious untreated medical condition
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01271413
| United States, Maryland | |
| BPRU, Johns Hopkins Bayview Medical Center | |
| Baltimore, Maryland, United States, 21224 | |
| Principal Investigator: | Miriam Z Mintzer, PhD | Johns Hopkins University |
| Responsible Party: | Miriam Mintzer, Associate Professor, Johns Hopkins University |
| ClinicalTrials.gov Identifier: | NCT01271413 |
| Other Study ID Numbers: |
NA_00042772 1R21DA029708 ( U.S. NIH Grant/Contract ) |
| First Posted: | January 6, 2011 Key Record Dates |
| Results First Posted: | March 7, 2014 |
| Last Update Posted: | April 16, 2014 |
| Last Verified: | March 2014 |
|
Substance-Related Disorders Chemically-Induced Disorders Mental Disorders |

